Clinical Trials · NCT07187830
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- University of Alberta
- Enrollment
- 52
- Start date
- Feb 2026
- Locations
- 1 site, Canada
- Primary endpoint
- Correlation between kidney disease progression and cardiometabolic changes